Orchard Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2022	FY 2021	FY 2020
Period Ending	Jun '23 Jun 30, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	39.91	40.47	34.41	23.99
Revenue Growth (YoY)	9.25%	17.59%	43.43%	-
Cost of Revenue	19.76	21.29	16.46	11.19
Gross Profit	20.15	19.17	17.95	12.8
Selling, General & Admin	30.56	26.72	23.65	16.88
Research & Development	10.26	12.96	14.01	8.43
Operating Expenses	40.81	39.68	37.67	25.31
Operating Income	-20.66	-20.51	-19.71	-12.51
Interest Expense	-11.63	-4.56	-1.97	-1.63
Other Non Operating Income (Expenses)	2.08	0.61	0.9	0.39
EBT Excluding Unusual Items	-29.24	-24.45	-20.78	-13.75
Merger & Restructuring Charges	-	-	-	-0.4
Gain (Loss) on Sale of Investments	-	-	-	-0.11
Gain (Loss) on Sale of Assets	-	-	0.64	1.98
Asset Writedown	-11.82	-7.16	-	-
Other Unusual Items	22.92	-1.55	0.61	-
Pretax Income	-18.14	-33.16	-19.53	-12.28
Income Tax Expense	0.34	-0.11	-0.73	-0.86
Earnings From Continuing Operations	-18.48	-33.05	-18.8	-11.42
Earnings From Discontinued Operations	-	-	-0.16	41.35
Net Income to Company	-18.48	-33.05	-18.96	29.93
Minority Interest in Earnings	0.52	0.63	1.3	0.84
Net Income	-17.96	-32.42	-17.66	30.77
Preferred Dividends & Other Adjustments	1.67	2.68	2.51	2.36
Net Income to Common	-19.63	-35.1	-20.17	28.42
Shares Outstanding (Basic)	29	11	9	9
Shares Outstanding (Diluted)	29	11	9	9
Shares Change (YoY)	319.65%	23.99%	2.73%	-
EPS (Basic)	-0.67	-3.11	-2.22	3.21
EPS (Diluted)	-0.67	-3.11	-2.22	3.21
Free Cash Flow	-18.88	-15.15	-12.64	-14.57
Free Cash Flow Per Share	-0.65	-1.34	-1.39	-1.64
Gross Margin	50.49%	47.38%	52.17%	53.34%
Operating Margin	-51.78%	-50.68%	-57.28%	-52.13%
Profit Margin	-49.19%	-86.74%	-58.61%	118.43%
Free Cash Flow Margin	-47.31%	-37.44%	-36.72%	-60.73%
EBITDA	-15.44	-12.59	-12.43	-7.82
EBITDA Margin	-38.69%	-31.11%	-36.13%	-32.58%
D&A For EBITDA	5.23	7.92	7.28	4.69
EBIT	-20.66	-20.51	-19.71	-12.51
EBIT Margin	-51.78%	-50.68%	-57.28%	-52.13%
Revenue as Reported	39.91	40.47	34.41	23.99
Advertising Expenses	-	-	-	1

Updated Aug 11, 2023. Source: S&P Global Market Intelligence. Standard template. Financial Sources.